We think that the Scottish Government and NHS Scotland must urgently work together to make sure that no child or young person is unable to access the care they need, when they need it. And we intend to keep making that case, as often as we can and wherever we can. Read more:

On July 5th, the Chief Medical Officer’s Directorate published the “Cass Review – Implications for Scotland: findings report”

On July 19th, we wrote to the Chief Medical Officer and the Minister for Public Health and Women’s Health alongside colleagues from LGBT Youth Scotland, LGBT Health and Wellbeing and LEAP Sports to outline our views on the report, and what we think are key considerations going forward to make sure that every single child and young person in Scotland – including trans, gender diverse and gender questioning children and young people – get the care they need when they need it.

Read the letter here: Letter-to-CMO-and-MPHWH-re-Cass-Review-implications-for-Scotland-findings-report-July-24.pdf

On October 29th, the Chief Medical Officer, Deputy Chief Medical Officer, and Chief Pharmaceutical Officer gave evidence to the Health, Social Care and Sport Committee about the future of gender identity services for children and young people. Read our briefing to Committee members here: https://www.scottishtrans.org/wp-content/uploads/2024/10/Scottish-Trans-Health-Committee-briefing-for-meeting-29.10.24.pdf 

• Information on the change in law on prescriptions for puberty blockers for under 18s

Our response to the:

• Publication of the final report of the Cass Review
• Decision to pause referrals for endocrine treatments for under 18s

Our briefing for MSPs on:

• • The Minister for Public Health and Women’s Health’s update on gender identity services for children and young people – September 2024
  • A debate on implementing the findings of the Cass Review in Scotland – May 2024
  • The decision to pause referrals for endocrine treatments for under 18s – April 2024